CN101560197B - Method for extracting paclitaxel from artificially cultivated yew branches and leaves - Google Patents
Method for extracting paclitaxel from artificially cultivated yew branches and leaves Download PDFInfo
- Publication number
- CN101560197B CN101560197B CN2009100227565A CN200910022756A CN101560197B CN 101560197 B CN101560197 B CN 101560197B CN 2009100227565 A CN2009100227565 A CN 2009100227565A CN 200910022756 A CN200910022756 A CN 200910022756A CN 101560197 B CN101560197 B CN 101560197B
- Authority
- CN
- China
- Prior art keywords
- paclitaxel
- taxol
- ramulus
- taxus
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title claims abstract description 123
- 229930012538 Paclitaxel Natural products 0.000 title claims abstract description 120
- 229960001592 paclitaxel Drugs 0.000 title claims abstract description 120
- 238000000034 method Methods 0.000 title claims abstract description 37
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 53
- 239000003208 petroleum Substances 0.000 claims abstract description 25
- YKYONYBAUNKHLG-UHFFFAOYSA-N n-Propyl acetate Natural products CCCOC(C)=O YKYONYBAUNKHLG-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229940090181 propyl acetate Drugs 0.000 claims abstract description 19
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 238000004128 high performance liquid chromatography Methods 0.000 claims abstract description 14
- 238000000605 extraction Methods 0.000 claims abstract description 12
- 239000002904 solvent Substances 0.000 claims abstract description 8
- 241001674343 Taxus x media Species 0.000 claims abstract description 4
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 51
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 34
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 28
- 239000000284 extract Substances 0.000 claims description 20
- -1 trifluoracetic acid octadecyl pyridine quaternary ammonium salt Chemical class 0.000 claims description 20
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 19
- 239000000741 silica gel Substances 0.000 claims description 16
- 229910002027 silica gel Inorganic materials 0.000 claims description 16
- 239000000203 mixture Substances 0.000 claims description 15
- 239000012141 concentrate Substances 0.000 claims description 13
- SRCZQMGIVIYBBJ-UHFFFAOYSA-N ethoxyethane;ethyl acetate Chemical compound CCOCC.CCOC(C)=O SRCZQMGIVIYBBJ-UHFFFAOYSA-N 0.000 claims description 12
- 241001149649 Taxus wallichiana var. chinensis Species 0.000 claims description 8
- 239000003480 eluent Substances 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- 239000000287 crude extract Substances 0.000 claims description 7
- 239000013078 crystal Substances 0.000 claims description 7
- 241001330459 Taxus wallichiana var. wallichiana Species 0.000 claims description 5
- 239000000945 filler Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims 3
- 239000000543 intermediate Substances 0.000 claims 2
- 235000008504 concentrate Nutrition 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 235000014666 liquid concentrate Nutrition 0.000 claims 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 239000008247 solid mixture Substances 0.000 claims 1
- 241001116500 Taxus Species 0.000 abstract description 12
- 239000002994 raw material Substances 0.000 abstract description 8
- 238000010898 silica gel chromatography Methods 0.000 abstract description 7
- 238000006257 total synthesis reaction Methods 0.000 abstract description 4
- 241000196324 Embryophyta Species 0.000 abstract description 3
- 238000003786 synthesis reaction Methods 0.000 abstract description 3
- 238000009776 industrial production Methods 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- 239000012071 phase Substances 0.000 description 22
- 241001116498 Taxus baccata Species 0.000 description 21
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- 239000000843 powder Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- DBXFAPJCZABTDR-KUEXGRMWSA-N Cephalomannine Natural products O=C(O[C@@H]1C(C)=C2[C@@H](OC(=O)C)C(=O)[C@]3(C)[C@@H](O)C[C@@H]4[C@](OC(=O)C)([C@H]3[C@H](OC(=O)c3ccccc3)[C@@](O)(C2(C)C)C1)CO4)[C@@H](O)[C@H](NC(=O)/C(=C\C)/C)c1ccccc1 DBXFAPJCZABTDR-KUEXGRMWSA-N 0.000 description 7
- DBXFAPJCZABTDR-WBYYIXQISA-N cephalomannine Chemical compound O([C@@H]1[C@]2(O)C[C@@H](C(=C([C@@H](OC(C)=O)C(=O)[C@]3(C)[C@@H](O)C[C@H]4OC[C@]4([C@H]31)OC(C)=O)C2(C)C)C)OC(=O)[C@H](O)[C@@H](NC(=O)C(/C)=C/C)C=1C=CC=CC=1)C(=O)C1=CC=CC=C1 DBXFAPJCZABTDR-WBYYIXQISA-N 0.000 description 7
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000013067 intermediate product Substances 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 4
- 238000004440 column chromatography Methods 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000003643 water by type Substances 0.000 description 4
- XXMFJKNOJSDQBM-UHFFFAOYSA-N 2,2,2-trifluoroacetic acid;hydrate Chemical compound [OH3+].[O-]C(=O)C(F)(F)F XXMFJKNOJSDQBM-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- QMMFVYPAHWMCMS-UHFFFAOYSA-N Dimethyl sulfide Chemical compound CSC QMMFVYPAHWMCMS-UHFFFAOYSA-N 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 238000004366 reverse phase liquid chromatography Methods 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- YWLXLRUDGLRYDR-ZHPRIASZSA-N 5beta,20-epoxy-1,7beta,10beta,13alpha-tetrahydroxy-9-oxotax-11-ene-2alpha,4alpha-diyl 4-acetate 2-benzoate Chemical compound O([C@H]1[C@H]2[C@@](C([C@H](O)C3=C(C)[C@@H](O)C[C@]1(O)C3(C)C)=O)(C)[C@@H](O)C[C@H]1OC[C@]12OC(=O)C)C(=O)C1=CC=CC=C1 YWLXLRUDGLRYDR-ZHPRIASZSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 239000005909 Kieselgur Substances 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000004896 high resolution mass spectrometry Methods 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- RZJRJXONCZWCBN-UHFFFAOYSA-N octadecane Chemical compound CCCCCCCCCCCCCCCCCC RZJRJXONCZWCBN-UHFFFAOYSA-N 0.000 description 2
- 239000012285 osmium tetroxide Substances 0.000 description 2
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 2
- 238000004810 partition chromatography Methods 0.000 description 2
- 238000004237 preparative chromatography Methods 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 238000004007 reversed phase HPLC Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- 238000010268 HPLC based assay Methods 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 241001116495 Taxaceae Species 0.000 description 1
- 241000015728 Taxus canadensis Species 0.000 description 1
- 244000162450 Taxus cuspidata Species 0.000 description 1
- 241001330449 Taxus wallichiana Species 0.000 description 1
- PMZXXNPJQYDFJX-UHFFFAOYSA-N acetonitrile;2,2,2-trifluoroacetic acid Chemical compound CC#N.OC(=O)C(F)(F)F PMZXXNPJQYDFJX-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000000692 cap cell Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 238000002114 high-resolution electrospray ionisation mass spectrometry Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 229940038384 octadecane Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- OZZVBAYDTTYGTJ-NOSCCTPQSA-N paclitaxel acetonitrile Chemical compound CC#N.O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 OZZVBAYDTTYGTJ-NOSCCTPQSA-N 0.000 description 1
- 238000005191 phase separation Methods 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000005556 structure-activity relationship Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
Images
Landscapes
- Epoxy Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
技术领域technical field
本发明内容属于生化物品制备技术领域,涉及一种从人工栽培的红豆杉枝叶中提取紫杉醇的方法。The content of the invention belongs to the technical field of preparation of biochemical products, and relates to a method for extracting paclitaxel from branches and leaves of yew artificially cultivated.
背景技术Background technique
紫杉醇(paclitaxel,taxol)是一种由红豆杉科(Taxaceae)红豆杉属(Taxus)植物的树皮、枝叶提取的化学结构复杂、作用机制独特的抗肿瘤药物。天然紫杉醇的来源极为有限,其主要来源于红豆杉或紫杉树皮(Wani等,J.Am.Chem.Soc.1971,93,2325)。红豆杉树种生长极其缓慢,一颗生长百年的老树一般只能剥25kg树皮,若提取1kg纯紫杉醇提供1万2千例癌病患者使用,相当于需3万株红豆杉树的树皮。为了得到紫杉醇,国内外开展了种植矮壮化的红豆杉树、组织培养、半合成和全合成紫杉醇等方法获取紫杉醇原料。但组织培养法获得的产量很小,培养液价格昂贵,全合成得率很小,且疗效不及天然源紫杉醇,成本高,难以商业化应用。半合成方法仍然需要天然红豆杉分离出的紫杉醇半合成的前体10-去乙酰基巴卡丁III等作为起始原料。为了保护天然的红豆杉资源,维护生态环境,用生长快的、有效成分含量较高的人工种植的红豆杉提取紫杉醇是最为有效的途径(高锦明等,紫杉醇资源开发研究,西北林学院学报,1997,12(3):94;高锦明等,抗癌新药紫杉醇的构效关系,西北农业大学学报,1997,25(5):96;高锦明等,紫杉醇资源、生物活性和化学合成,世界林业研究,1997,10(6):38;Gragg等,J.Nat.Prod.,1993,56,1657;Kingston,Phytochemistry,2007,68,1844)。Paclitaxel (taxol) is an antineoplastic drug with complex chemical structure and unique mechanism of action extracted from the bark, branches and leaves of Taxus (Taxaceae) plants. The sources of natural paclitaxel are very limited, mainly from yew or yew bark (Wani et al., J. Am. Chem. Soc. 1971, 93, 2325). The growth of yew tree species is extremely slow. Generally, a century-old tree can only peel 25kg of bark. If 1kg of pure taxol is extracted to provide 12,000 cancer patients, it is equivalent to the bark of 30,000 yew trees. . In order to obtain paclitaxel, methods such as planting dwarf yew trees, tissue culture, semi-synthesis and total synthesis of paclitaxel have been carried out at home and abroad to obtain paclitaxel raw materials. However, the yield obtained by the tissue culture method is very small, the culture medium is expensive, the total synthesis yield is very small, and the curative effect is not as good as that of natural source paclitaxel, the cost is high, and it is difficult to commercialize it. The semi-synthetic method still requires paclitaxel semi-synthetic precursor 10-deacetylbaccatin III isolated from natural yew as starting materials. In order to protect the natural taxus resources and maintain the ecological environment, it is the most effective way to extract paclitaxel from the artificially planted taxus with fast growth and higher active ingredient content (Gao Jinming, etc., paclitaxel resource development research, Journal of Northwest Forestry University, 1997 , 12(3): 94; Gao Jinming et al., The Structure-Activity Relationship of New Anticancer Drug Paclitaxel, Journal of Northwest Agricultural University, 1997, 25(5): 96; Gao Jinming et al., Taxol Resources, Biological Activity and Chemical Synthesis, World Forestry Research, 1997, 10(6):38; Gragg et al., J. Nat. Prod., 1993, 56, 1657; Kingston, Phytochemistry, 2007, 68, 1844).
Miller(J.Org.Chem.,1981,46,1469)用(Taxus wallichiana)树干和树叶,用甲醇提取、浓缩,在己烷和水中分配,用氯仿萃取,浓缩,经几次硅胶柱色谱分离;经二次逆流分配;最后用HPLC分离纯化得到184个组分,所得的紫杉醇纯度99.1%。整个提取纯化过程有八个步骤。Senilh等(J.Nat.Prod.,1984,47,131)用甲醇提取欧洲紫杉(T.baccata)树皮,浓缩后,在二氯甲烷和水中分配,经硅胶柱色谱分离,然后经氧化铝柱色谱分离;再经中压硅胶柱色谱分离;最后用制备高压液相色谱纯化。Miller (J.Org.Chem., 1981, 46, 1469) used (Taxus wallichiana) trunk and leaves, extracted with methanol, concentrated, distributed in hexane and water, extracted with chloroform, concentrated, and separated by silica gel column chromatography several times ; Secondary countercurrent distribution; finally separated and purified by HPLC to obtain 184 components, the resulting paclitaxel purity 99.1%. The whole extraction and purification process has eight steps. Senilh et al. (J.Nat.Prod., 1984, 47, 131) extracted the bark of European yew (T.baccata) with methanol, concentrated, distributed in dichloromethane and water, separated by silica gel column chromatography, and then oxidized Separated by aluminum column chromatography; then separated by medium pressure silica gel column chromatography; finally purified by preparative high pressure liquid chromatography.
Nalr(USP 5,279,949,1994)发明了用红豆杉(T.media cv.Hicksii)的新鲜枝叶提取紫杉醇及其类似物。新鲜枝叶用含水甲醇提取,水溶性组分离心与含紫杉醇的固体沉淀分离,过滤后的滤液用活性炭脱色用硅藻土过滤,滤液挥发至干,经硅胶柱,液相分离得到产物。或者将硅藻土过滤的滤液真空下脱甲醇后,用乙酸乙酯萃取,萃取液浓缩,经硅胶柱纯化得到产物。Nalr(USP 5,478,736,1995)用甲醇和丙酮萃取新鲜枝叶,可得到较高的紫杉醇产量。二次柱色谱分离,低压硅胶柱色谱分离粗紫杉醇,反相色谱最后纯化。Nalr (USP 5,279,949,1994) invented the extraction of paclitaxel and its analogues from the fresh branches and leaves of yew (T.media cv.Hicksii). The fresh branches and leaves are extracted with aqueous methanol, the water-soluble components are centrifuged and separated from the solid precipitation containing paclitaxel, the filtered filtrate is decolorized with activated carbon and filtered with diatomaceous earth, the filtrate is evaporated to dryness, and the product is obtained by liquid phase separation through a silica gel column. Alternatively, demethanolize the filtrate filtered through diatomaceous earth under vacuum, extract it with ethyl acetate, concentrate the extract, and purify it through a silica gel column to obtain the product. Nalr (USP 5,478,736,1995) extracts fresh branches and leaves with methanol and acetone, which can obtain higher paclitaxel production. Separation by secondary column chromatography, separation of crude paclitaxel by low-pressure silica gel column chromatography, and final purification by reverse phase chromatography.
Polysciences公司从太平洋紫杉树皮中分离紫杉醇。先甲醇或乙醇提取树皮,浓缩;浓缩液用二氯甲烷萃取,浓缩干燥至粉末;粉末用丙醇和里格罗因(1∶1)溶解,不溶组分过滤除去;滤液浓缩,溶于30%丙醇里格罗因溶液,经Florisil柱过滤;从柱中流出的紫杉醇组分结晶纯化二次;结晶的紫杉醇再用硅胶柱中分离,结构相似的产物三尖杉宁碱从紫杉醇中分离出来;从柱中流出的紫杉醇重结晶二次,得到紫杉醇。Rao等(USP5,380,916,1992)介绍了用臭氧处理难分离的杂质组分三尖杉宁碱而得紫杉醇。经反相制备色谱法分离粗产品后,仍含有很难分开的三尖杉宁碱,通入臭氧氧化后,经过反相制备色谱分离得到纯度较高的紫杉醇。该方法要使用二甲硫醚处理溶液中残留的臭氧及重结晶得到紫杉醇纯品。Kingston等(J.Nat.Prod.,1992,55,259)使用氧化剂四氧化锇处理紫杉醇和三尖杉宁碱的混合物。紫杉醇不与四氧化锇反应,三尖杉宁碱的C-13侧链末端双键被氧化,易与紫杉醇分开。Durand(USP 5,723,635,1998)利用离心分配色谱法分离纯化紫杉醇。用C18反相色谱柱从粗产物中分离纯化紫杉醇,一次处理量较大。主要有四个步骤:在制备规模下,用反相色谱法处理紫杉醇粗提物;从吸附剂上洗脱紫杉醇和其它产物;从洗脱的柱子中回收紫杉醇和类似物;使用臭氧处理最终产物,从而分离除去紫杉醇的类似物。Polysciences isolated paclitaxel from Pacific yew bark. First extract the bark with methanol or ethanol, concentrate; extract the concentrate with dichloromethane, concentrate and dry to powder; % propanol ligroin solution, filtered through a Florisil column; the paclitaxel component flowing out from the column was crystallized and purified twice; the crystallized paclitaxel was separated on a silica gel column, and the product cephalomannine with a similar structure was separated from paclitaxel out; paclitaxel flowing out from the column is recrystallized twice to obtain paclitaxel. Rao et al. (USP 5,380,916, 1992) introduced the use of ozone to treat the difficult-to-separate impurity component cephalomannine to obtain paclitaxel. After the crude product is separated by reverse-phase preparative chromatography, it still contains cephalomannine which is difficult to separate. After being oxidized by ozone, it is separated by reverse-phase preparative chromatography to obtain paclitaxel with high purity. The method uses dimethyl sulfide to treat residual ozone in the solution and recrystallizes to obtain pure paclitaxel. Kingston et al. (J. Nat. Prod., 1992, 55, 259) treated a mixture of paclitaxel and cephalomannine with the oxidizing agent osmium tetroxide. Paclitaxel does not react with osmium tetroxide, and the double bond at the end of the C-13 side chain of cephalomannine is oxidized, so it is easy to separate from paclitaxel. Durand (USP 5,723,635, 1998) used centrifugal partition chromatography to separate and purify paclitaxel. Paclitaxel was separated and purified from the crude product with a C 18 reverse-phase chromatographic column, and the amount of treatment at one time was relatively large. There are four main steps: treatment of crude paclitaxel extract by reversed-phase chromatography at preparative scale; elution of paclitaxel and other products from the adsorbent; recovery of paclitaxel and analogues from the eluted column; treatment of the final product with ozone , thereby isolating and removing the analogs of paclitaxel.
Rao(USP 5,380,916,1995)用95%甲醇提取树皮,浓缩,氯仿和水萃取。连续萃取3次,氯仿相浓缩,在C18填料层析柱上用乙腈和水梯度洗脱,分段接收含紫杉醇较高的馏分,用热水稀释后,用反相柱再收集馏分,经重结晶得到高纯度的紫杉醇及其类似物。陈建民等发明了一种从种植红豆杉叶枝中制备紫杉醇的方法(ZL 1427002)。用乙醇浸泡,乙酸丁酯萃取,浓缩,得到1%紫杉醇粗原料,再经硅胶柱层析,以环己烷和乙酸乙酯梯度洗脱,收集含10%以上紫杉醇的馏分,浓缩后经反相高压液相色谱法分离,得到高纯度紫杉醇。Rao (USP 5,380,916, 1995) extracted the bark with 95% methanol, concentrated, extracted with chloroform and water. Continuous extraction for 3 times, concentration of chloroform phase, gradient elution with acetonitrile and water on the C18 packed chromatography column, receiving fractions with higher paclitaxel in sections, diluting with hot water, collecting fractions with reversed-phase column, through High-purity paclitaxel and its analogues were obtained by recrystallization. Chen Jianmin etc. have invented a kind of method (ZL 1427002) of preparing paclitaxel from planting yew leaf branch. Soak in ethanol, extract with butyl acetate, concentrate to get 1% paclitaxel crude raw material, then go through silica gel column chromatography, elute with cyclohexane and ethyl acetate gradient, collect the fractions containing more than 10% paclitaxel, concentrate and go through reaction phase high-pressure liquid chromatography to obtain high-purity paclitaxel.
对于红豆杉提取紫杉醇的分离纯化多为使用低级醇溶剂浸提树皮,提取液先进行脱脂后氯仿萃取;氯仿层浓缩,经柱层析得到紫杉醇及其类似物。常用的色谱柱层析法需要多次正、反相液相色谱法、离心分配色谱法等,还包括结晶法、氧化去杂质法。分离过程步骤繁琐,达到99%以上纯度的紫杉醇一次得率较低。溶剂、洗脱液等毒性大,造成严重的污染。此外,紫杉醇与三尖杉宁碱、7-表-紫杉醇和7-表-10-去乙酰基紫杉醇的性质相似,难以分离(Yang等,J.Chromatogr.A,1998,813,201)。从紫杉醇样品中有效剔除这些结构类似物是提取高纯度紫杉醇的关键所在。For the separation and purification of Taxus paclitaxel, the lower alcohol solvent is used to extract the bark, and the extract is first degreased and then extracted with chloroform; the chloroform layer is concentrated, and Paclitaxel and its analogs are obtained by column chromatography. Commonly used chromatographic column chromatography requires multiple forward and reverse phase liquid chromatography, centrifugal partition chromatography, etc., and also includes crystallization and oxidation to remove impurities. The steps of the separation process are cumbersome, and the primary yield of paclitaxel with a purity of more than 99% is low. Solvents, eluents, etc. are highly toxic and cause serious pollution. In addition, paclitaxel has similar properties to cephalomannine, 7-epi-paclitaxel and 7-epi-10-deacetyl paclitaxel, and it is difficult to separate them (Yang et al., J. Chromatogr. A, 1998, 813, 201). Effectively removing these structural analogues from paclitaxel samples is the key to extracting high-purity paclitaxel.
发明内容Contents of the invention
本发明的目的是提供一种从人工栽培的红豆杉枝叶中制备紫杉醇的方法,该方法工艺简单,易于分离掉紫杉醇的结构类似物,所得的紫杉醇纯度高。The object of the present invention is to provide a method for preparing paclitaxel from branches and leaves of yew artificially cultivated. The method is simple in process, easy to separate the structural analogs of paclitaxel, and the obtained paclitaxel has high purity.
为达到上述目的,本发明采用的技术方案为:In order to achieve the above object, the technical scheme adopted in the present invention is:
一种从人工栽培的红豆杉枝叶中制备紫杉醇的方法,其依次包括如下步骤:A method for preparing paclitaxel from artificially cultivated yew branches and leaves, which comprises the steps in turn:
A、将红豆杉枝叶粉碎后,在40~50℃下用75%~95%甲醇浸泡3次,每次4小时,将滤液浓缩后用体积比为4∶1~1∶1石油醚/水萃取;分出下层水相;A. After the yew branches and leaves are crushed, soak them with 75% to 95% methanol for 3 times at 40 to 50°C, each time for 4 hours, and use a volume ratio of 4:1 to 1:1 petroleum ether/water after the filtrate is concentrated. Extraction; Separate the lower aqueous phase;
B、用乙酸丙酯萃取下层水相;乙酸丙酯萃取液浓缩,得到紫杉醇含量在2%~5%以上紫杉醇粗提物;B. Extract the lower aqueous phase with propyl acetate; concentrate the propyl acetate extract to obtain a paclitaxel crude extract with a paclitaxel content of more than 2% to 5%;
C、将2%以上紫杉醇粗提物同硅胶混合制备干样,填充了干样到硅胶(200~300目)的色谱柱上端,分别用4∶1的石油醚-乙酸乙酯、1∶1的石油醚-乙酸乙酯、1∶5的石油醚-乙酸乙酯及乙酸乙酯洗脱,按段将紫杉醇含量在15%~40%之间的洗脱液馏分集中起来,经浓缩、干燥,制得中间产品;C. Mix more than 2% paclitaxel crude extract with silica gel to prepare a dry sample, fill the dry sample to the upper end of the chromatographic column of silica gel (200-300 mesh), and use 4:1 petroleum ether-ethyl acetate, 1:1 respectively Petroleum ether-ethyl acetate, 1:5 petroleum ether-ethyl acetate and ethyl acetate were eluted, and the eluate fractions with paclitaxel content between 15% and 40% were collected in sections, concentrated and dried , to produce intermediate products;
D、将步骤C所得的中间产品用体积比为30∶70的乙腈和含0.1%三氟醋酸水溶解,用高压液相色谱分离,色谱柱为C18硅胶填料,以含三氟醋酸十八烷基吡啶季銨盐的乙腈和含0.1%三氟醋酸水为流动相,收集洗脱液,浓缩,析出紫杉醇晶体和三氟醋酸十八烷基吡啶季銨盐固体的混合物。D, the intermediate product obtained in step C is dissolved in acetonitrile and water containing 0.1% trifluoroacetic acid with a volume ratio of 30:70, and separated by high-pressure liquid chromatography. Acetonitrile of alkylpyridinium quaternary ammonium salt and water containing 0.1% trifluoroacetic acid are used as mobile phases, the eluate is collected, concentrated, and a mixture of paclitaxel crystals and octadecylpyridinium trifluoroacetic acid quaternary ammonium salt solid is separated out.
此混合物经离心,水洗,再离心,水洗,过滤,冷冻干燥,得到纯度为99.6%以上的紫杉醇。The mixture is centrifuged, washed with water, centrifuged again, washed with water, filtered and freeze-dried to obtain paclitaxel with a purity of more than 99.6%.
上述的洗脱液和流动相中的溶剂经过精馏后可重复使用。The above eluent and the solvent in the mobile phase can be reused after rectification.
上述的步骤A中人工栽培的红豆杉为曼地亚红豆杉、云南红豆杉或东北红豆杉。The yew artificially cultivated in the above step A is Taxus Mandia, Taxus Yunnan or Taxus chinensis.
上述的步骤D中的三氟醋酸十八烷基吡啶季銨盐浓度为2~15mg/mL。The concentration of octadecylpyridinium quaternary ammonium trifluoroacetate in step D above is 2-15 mg/mL.
上述的步骤D中的流动相乙腈-0.1%三氟醋酸水的体积比为30∶70。The volume ratio of the mobile phase acetonitrile-0.1% trifluoroacetic acid water in the above step D is 30:70.
上述的步骤D所得到的三氟醋酸十八烷基吡啶季銨盐,经过水洗,离心过滤,冷冻干燥后可重复使用。The octadecylpyridinium trifluoroacetic acid quaternary ammonium salt obtained in the above step D can be reused after being washed with water, centrifugally filtered, and freeze-dried.
本发明相对于现有技术,其优点如下:Compared with the prior art, the present invention has the following advantages:
该方法工艺简单、成本低、溶剂、洗脱剂可以回收,适合于工业化生产,且保护了植物资源。The method has simple process, low cost, recyclable solvent and eluent, is suitable for industrial production, and protects plant resources.
附图说明:Description of drawings:
图1是从红豆杉枝叶中提取纯化紫杉醇的工艺流程图;Fig. 1 is the process flow diagram of extracting and purifying paclitaxel from the branches and leaves of Chinese yew;
图2是红豆杉枝叶粗提物的高效液相色谱图;Fig. 2 is the high-performance liquid chromatogram of the crude extract of yew branches and leaves;
图3是紫杉醇含量在15%以上的高效液相色谱图;Figure 3 is a high performance liquid chromatogram with paclitaxel content above 15%;
图4是紫杉醇晶体和三氟醋酸十八烷基吡啶季銨盐的高效液相色谱图;Fig. 4 is the high performance liquid phase chromatogram of paclitaxel crystal and octadecylpyridinium trifluoroacetate quaternary ammonium salt;
图5是分离纯度99.6%以上紫杉醇的高效液相色谱图。Fig. 5 is a high-performance liquid chromatogram of paclitaxel with an isolation purity of 99.6% or more.
具体实施方式Detailed ways
本发明是以人工栽培的曼地亚红豆杉、云南红豆杉、南方红豆杉或东北红豆杉的枝叶为原料,经甲醇浸泡提取、依次用石油醚和乙酸丙酯萃取,然后用常压正相硅胶柱层析法及反相高压液相色谱分离法得到高纯度紫杉醇。The present invention uses artificially cultivated branches and leaves of Taxus chinensis, Taxus yunnanensis, Taxus chinensis or Taxus chinensis as raw materials, soaks and extracts them in methanol, extracts them with petroleum ether and propyl acetate in sequence, and then uses normal pressure normal phase High-purity paclitaxel was obtained by silica gel column chromatography and reversed-phase high-pressure liquid chromatography.
本发明所采用的技术方案是:一种从人工栽培的红豆杉枝叶中提取紫杉醇的方法,依次包括如下步骤:The technical scheme adopted in the present invention is: a kind of method for extracting paclitaxel from the artificially cultivated yew branches and leaves, comprising the following steps successively:
(1)将人工栽培的三年红豆杉的树枝叶粉碎后,在40~50℃下,用75~95%的甲醇浸泡三次,每次4小时,合并滤液,浓缩,后用体积比为4∶1石油醚/水萃取,分出下层,用等体积的乙酸丙酯萃取下层水相;(1) After the branches and leaves of the three-year yew artificially cultivated are crushed, soak them three times with 75-95% methanol at 40-50° C., each time for 4 hours, combine the filtrates, concentrate, and use a volume ratio of 4 : 1 petroleum ether/water extraction, separate the lower layer, and extract the lower layer aqueous phase with an equal volume of propyl acetate;
(2)将乙酸丙酯萃取液浓缩,得到紫杉醇含量在2%以上的紫杉醇浓缩液;(2) concentrating the propyl acetate extract to obtain a paclitaxel concentrate with a paclitaxel content of more than 2%;
(3)将2%以上的紫杉醇浓缩液与硅胶伴样,并填充于硅胶柱上,用洗脱液梯度洗脱,分别加入石油醚和乙酸乙酯(4∶1)、石油醚和乙酸乙酯(1∶1)、石油醚和乙酸乙酯(1∶5)、乙酸乙酯,洗脱液流出色谱柱后分段收集馏分,按段将紫杉醇含量15%~40%之间的洗脱液馏分收集合并,经浓缩、干燥,制得中间产品;(3) Companion more than 2% paclitaxel concentrate with silica gel, and fill it on a silica gel column, elute with eluent gradient, add petroleum ether and ethyl acetate (4:1), petroleum ether and ethyl acetate Esters (1:1), petroleum ether and ethyl acetate (1:5), ethyl acetate, after the eluent flows out of the chromatographic column, the fractions are collected in sections, and the paclitaxel content between 15% and 40% is eluted in sections The liquid fractions were collected and combined, concentrated and dried to obtain an intermediate product;
(4)将步骤(3)和步骤(4)所得的中间产品用乙腈和含0.1%三氟醋酸水(30∶70)溶解,用C18反相高压液相色谱分离,以含三氟醋酸十八烷基吡啶季銨盐的乙腈和含0.1%三氟醋酸水(30∶70)为流动相,而后将分离后的含紫杉醇的流动相浓缩到一定体积,析出紫杉醇晶体和三氟醋酸十八烷基吡啶季銨盐固体的混合物。(4) Dissolve the intermediate product obtained in step (3) and step (4) with acetonitrile and water (30:70) containing 0.1% trifluoroacetic acid, and separate with C 18 reverse-phase high-pressure liquid chromatography to obtain trifluoroacetic acid-containing The acetonitrile of octadecylpyridinium quaternary ammonium salt and water (30:70) containing 0.1% trifluoroacetic acid are mobile phases, then the mobile phase containing paclitaxel after the separation is concentrated to a certain volume, and paclitaxel crystals and trifluoroacetic acid decaclitaxel are separated out. Mixture of octaalkylpyridine quaternary ammonium salts solid.
(5)将步骤(4)所得的紫杉醇和三氟醋酸十八烷基吡啶季銨盐的混合物,经(5) the mixture of paclitaxel and octadecylpyridinium trifluoroacetate quaternary ammonium salt of step (4) gained, through
离心,水洗,再离心,过滤,冷冻干燥,得到纯度达99.6%以上的紫杉醇。Centrifuge, wash with water, centrifuge again, filter, and freeze-dry to obtain paclitaxel with a purity of more than 99.6%.
步骤(1)中的红豆杉为曼地亚红豆杉(T.media)、云南红豆杉(T.yunnanensis)、或东北红豆杉(T.cuspidata)。The yew in the step (1) is Taxus mandia (T.media), Taxus yunnanensis (T.yunnanensis), or Taxus chinensis (T.cuspidata).
本发明提取紫杉醇的方法过程如图1所示。图1所示的工艺过程分为三个过程。The process of the method for extracting paclitaxel of the present invention is shown in Figure 1. The process shown in Figure 1 is divided into three processes.
第一过程:利用人工栽培的新鲜或干燥的红豆杉枝叶粉碎后,在40~50℃用75%~95%甲醇浸泡三次,每次4小时,原料和甲醇的投料体积比1∶3~1∶8浸泡液过滤去除滤渣,滤液(HPLC分析见图2)置于旋转蒸发仪或浓缩罐中浓缩,加入体积比为1∶1石油醚/水萃取,搅拌30min,放置约20~30min,形成上层淡绿色清液及下层深绿色胶状液,分出上层石油醚相,连续萃取3次。下层水相用同体积的乙酸丙酯萃取后,乙酸丙酯萃取液,放置0.5~1小时后,将乙酸丙酯层与水层分开,取乙酸丙酯层蒸发浓缩干燥得到暗绿色或棕色粉末,所得紫杉醇含量在2%以上。The first process: Utilize artificially cultivated fresh or dried yew branches and leaves to be pulverized, soak them with 75%-95% methanol three times at 40-50°C, each time for 4 hours, and the volume ratio of raw materials and methanol is 1:3-1 : 8 soaking solution filtered to remove the filter residue, the filtrate (HPLC analysis see Figure 2) is placed in a rotary evaporator or a concentration tank to concentrate, adding a volume ratio of 1:1 petroleum ether/water for extraction, stirring for 30 minutes, and standing for about 20 to 30 minutes to form The upper layer of light green clear liquid and the lower layer of dark green colloidal liquid were separated from the upper layer of petroleum ether phase and extracted continuously for 3 times. After the lower aqueous phase is extracted with the same volume of propyl acetate, the propyl acetate extract is placed for 0.5 to 1 hour, and the propyl acetate layer is separated from the water layer, and the propyl acetate layer is evaporated, concentrated and dried to obtain a dark green or brown powder , the obtained paclitaxel content is more than 2%.
第二过程:将紫杉醇含量在2%以上的粗提物,用丙酮溶解,与硅胶(200-300目)混合制备干样。将干样置于硅胶柱上端,用石油醚和乙酸乙酯的混合溶剂梯度洗脱,用相同体积的容器接收得到相同体积的馏分1-20。馏分9-15蒸干后,为黄色或绿黄色固体粉末,其紫杉醇含量在15.0~40.0%之间(图3)。该过程中紫杉醇含量在15.0~40.0%之间的馏分合并蒸干,用乙腈和含0.1%三氟醋酸水(30∶70)溶解,进行紫杉醇的下一步纯化。The second process: the crude extract with a paclitaxel content above 2% is dissolved in acetone and mixed with silica gel (200-300 mesh) to prepare a dry sample. The dry sample was placed on the upper end of the silica gel column, and the mixed solvent of petroleum ether and ethyl acetate was used for gradient elution, and a container of the same volume was used to receive fractions 1-20 of the same volume. Fractions 9-15 are yellow or greenish-yellow solid powder after being evaporated to dryness, and the paclitaxel content is between 15.0% and 40.0% (Fig. 3). During this process, fractions with a paclitaxel content between 15.0% and 40.0% were combined and evaporated to dryness, and dissolved in acetonitrile and water containing 0.1% trifluoroacetic acid (30:70) for further purification of paclitaxel.
第三过程:用C18反相高效液相色谱柱,注入25%紫杉醇粗提物10克乙腈水溶液,以含三氟醋酸十八烷基吡啶季銨盐的乙腈和含0.1%三氟醋酸水(30∶70)为流动相,承接得到馏分1-35。该过程中,馏分15-25在旋转蒸发仪中真空浓缩到一定体积后,析出紫杉醇和三氟醋酸十八烷基吡啶季銨盐的混合物(图4),再通过离心,水洗,再离心,过滤,冷冻干燥,得到纯度为99.9%以上的紫杉醇(图5)。The third process: with C 18 reverse phase high performance liquid chromatography column, inject 10 grams of acetonitrile aqueous solution of 25% paclitaxel crude extract, with the acetonitrile containing trifluoroacetic acid octadecyl pyridinium quaternary ammonium salt and containing 0.1% trifluoroacetic acid water (30:70) was the mobile phase, and fractions 1-35 were obtained. In this process, after the fraction 15-25 is vacuum-concentrated to a certain volume in a rotary evaporator, a mixture of paclitaxel and octadecylpyridinium trifluoroacetate quaternary ammonium salt is separated out (Figure 4), and then centrifuged, washed with water, and centrifuged again. Filtration and lyophilization yielded paclitaxel with a purity of over 99.9% ( FIG. 5 ).
本发明方法与现有的紫杉醇提取工艺相比步骤少、工艺简单、生产成本低,有利于紫杉醇的工业化大生产,且不破坏天然资源、有利于生态环境保护;不使用毒性较大的试剂、溶剂,符合环保要求;紫杉醇的一次得率高,纯度可达99.6%以上。Compared with the existing paclitaxel extraction process, the method of the present invention has fewer steps, simple process, and low production cost, is beneficial to the industrialized large-scale production of paclitaxel, does not destroy natural resources, and is beneficial to ecological environment protection; no toxic reagents, The solvent meets the requirements of environmental protection; the yield of paclitaxel is high, and the purity can reach more than 99.6%.
本发明所用的石油醚、乙酸丙酯、乙酸乙酯、甲醇、三氟醋酸、醋酸、三氟醋酸十八烷基吡啶季銨盐等均为分析纯。乙腈为HPLC级,使用的水为HPLC级和去离子水。Petroleum ether, propyl acetate, ethyl acetate, methanol, trifluoroacetic acid, acetic acid, octadecylpyridinium trifluoroacetic acid quaternary ammonium salt etc. used in the present invention are analytically pure. Acetonitrile was HPLC grade and the water used was HPLC grade and deionized water.
原料、中间产品及紫杉醇的分析均采用美国Waters高压液相色谱仪,色谱柱为美国Waters产品SymmetryShield RP 18硅胶色谱柱(50×4.6mm),安装加拿大Missisawaga公司生产的Warters产品SymmetryShieldC18保护柱(3.9×20mm),填料尺寸均为3.5μm,Waters 996二级管阵列检测器(210~500nm),流动相为乙腈+水+0.1%TFA,乙腈比例从20%上升到80%,流速为1ml/min,自动进样,进样量为10μL。色谱柱用恒温箱,柱温为20℃,计算机操作,色谱软件为Millennium32。The analysis of raw material, intermediate product and paclitaxel all adopts U.S. Waters high-pressure liquid chromatograph, and chromatographic column is U.S. Waters product SymmetryShield RP 18 silica gel chromatographic column (50 * 4.6mm), installs the Warters product SymmetryShieldC 18 protection column ( 3.9×20mm), the filler size is 3.5μm, Waters 996 diode array detector (210~500nm), the mobile phase is acetonitrile+water+0.1%TFA, the proportion of acetonitrile increases from 20% to 80%, and the flow rate is 1ml /min, automatic injection, the injection volume is 10μL. The chromatographic column uses an incubator, the column temperature is 20°C, the computer is operated, and the chromatographic software is Millennium 32 .
高纯度紫杉醇制备采用美国Waters高压液相色谱仪系统,色谱柱为美国JM Science公司生产的Shiseido Capcell Pak C18,填料尺寸为5μm、色谱柱尺寸为4.6mm×250mm或4.6cm×150cm,分析波长为227nm,流动相为含三氟醋酸十八烷基吡啶季銨盐的乙腈+0.1%TFA水(30+70),流速为1.0ml/min,自动进样,每20min收集。The high-purity paclitaxel was prepared using the Waters high-pressure liquid chromatography system in the United States. The chromatographic column was Shiseido Capcell Pak C18 produced by JM Science in the United States. 227nm, the mobile phase is acetonitrile + 0.1% TFA water (30+70) containing octadecylpyridinium trifluoroacetic acid quaternary ammonium salt, the flow rate is 1.0ml/min, automatic sampling, collected every 20min.
高分辨质谱分析在英国Micromass公司生产的Micromass WatersQ-TOF Global质谱仪上进行,+ESI源。High-resolution mass spectrometry was performed on a Micromass WatersQ-TOF Global mass spectrometer produced by Micromass, UK, +ESI source.
实施例1:Example 1:
如图1所示,从人工栽培的红豆杉枝叶中提取紫杉醇的方法为:As shown in Figure 1, the method for extracting paclitaxel from the artificially cultivated yew branches and leaves is:
(1)取人工栽培的曼地亚红豆杉干枝叶1kg,用破碎机粉碎,5L圆底烧瓶中,加入90%甲醇3L,搅拌均匀,在40~50℃下浸泡三次,每次4~6小时。放置过程中搅拌3~6次,浸泡完成后,过滤,去除废渣,将滤液浓缩至呈浅绿色粘稠液,体积约为50ml。向溶液加入2L石油醚,混合均匀后加入2L水,搅拌30min,放置约25min,形成上层淡绿色清液及下层深绿色胶状液,分出上层石油醚相,如此连续萃取3次,除去脂溶性色素等杂质。向分出的下层水相中加入2L乙酸丙酯,搅拌30min,放置约25min,连续萃取3次,合并三次乙酸丙酯萃取液。(1) Take 1 kg of dry branches and leaves of Taxus chinensis artificially cultivated, crush them with a crusher, add 3 L of 90% methanol to a 5 L round bottom flask, stir well, soak three times at 40-50 ° C, each time 4-6 Hour. Stir 3 to 6 times during the standing process. After soaking, filter to remove waste residue, and concentrate the filtrate to a light green viscous liquid with a volume of about 50ml. Add 2L of petroleum ether to the solution, mix well, add 2L of water, stir for 30 minutes, and let it stand for about 25 minutes to form a light green clear liquid in the upper layer and a dark green gelatinous liquid in the lower layer. Soluble pigments and other impurities. Add 2 L of propyl acetate to the separated lower aqueous phase, stir for 30 min, let stand for about 25 min, extract continuously for 3 times, and combine the three propyl acetate extracts.
(2)将乙酸丙酯萃取液减压蒸发至干,形成棕色粉末,重量为12.6克,经测定紫杉醇含量为3.28%,下层混悬液中不含紫杉醇。(2) The propyl acetate extract was evaporated to dryness under reduced pressure to form a brown powder with a weight of 12.6 grams. The paclitaxel content was determined to be 3.28%, and the suspension in the lower layer did not contain paclitaxel.
(3)将含量3.28%以上乙酸丙酯粉末,用丙酮溶解,同硅胶混合制备干样。干样置于硅胶柱上端,分别用0.3L的石油醚-乙酸乙酯(4∶1)、0.3L的石油醚-乙酸乙酯(1∶1)、0.5L的石油醚-乙酸乙酯(1∶5)和0.2L乙酸乙酯洗脱,用相同体积的容器接收得到相同体积的馏分1-20。馏分6-8中,含有较多7-表-10-去乙酰基紫杉醇及7-表紫杉醇,馏分9-15蒸干后,为黄色或绿黄色固体粉末。馏分9-15中紫杉醇含量在15.0%~35.0%之间。(3) Dissolve propyl acetate powder with a content of more than 3.28% in acetone, and mix it with silica gel to prepare a dry sample. The dry sample was placed on the upper end of the silica gel column, and 0.3L of petroleum ether-ethyl acetate (4:1), 0.3L of petroleum ether-ethyl acetate (1:1), and 0.5L of petroleum ether-ethyl acetate ( 1:5) and 0.2 L of ethyl acetate, receiving the same volume of fractions 1-20 in the same volume of vessel. Fractions 6-8 contain more 7-epi-10-deacetyl-paclitaxel and 7-epi-paclitaxel, and fractions 9-15 are yellow or green-yellow solid powder after evaporation to dryness. The content of paclitaxel in fractions 9-15 is between 15.0% and 35.0%.
(4)称取含量27.5%紫杉醇样品10克,用50ml的乙腈和含0.1%三氟醋酸水(30∶70)溶解,经C18反相高压液相色谱法分离纯化,加入27.5%紫杉醇乙腈-水溶液,以含三氟醋酸十八烷基吡啶季銨盐(3mg/mL)的乙腈和含0.1%三氟醋酸水(30∶70)为流动相,流速为1ml/min,收集馏分1-35。馏分1-14蒸干后分析表明为杂质组分,含有较多量三尖杉宁碱,少量紫杉醇(2.8%以下)及7-表-10-去乙酰基紫杉醇。馏分15-25,浓缩到一定体积,析出紫杉醇晶体和三氟醋酸十八烷基吡啶季銨盐固体的混合物。(4) Take 10 grams of paclitaxel samples with a content of 27.5%, dissolve them with 50ml of acetonitrile and water (30:70) containing 0.1% trifluoroacetic acid, separate and purify by C 18 reverse phase high pressure liquid chromatography, add 27.5% paclitaxel acetonitrile -Aqueous solution, with acetonitrile containing trifluoroacetic acid octadecylpyridinium quaternary ammonium salt (3mg/mL) and water (30:70) containing 0.1% trifluoroacetic acid as mobile phase, flow rate is 1ml/min, collect fraction 1- 35. Analysis of fractions 1-14 after evaporating to dryness showed that they were impurity components, containing a relatively large amount of cephalomannine, a small amount of paclitaxel (below 2.8%) and 7-epi-10-deacetyl paclitaxel. Fractions 15-25 were concentrated to a certain volume, and a mixture of paclitaxel crystals and octadecylpyridinium quaternary ammonium trifluoroacetate solid was precipitated.
(5)将步骤(4)所得到的紫杉醇和三氟醋酸十八烷基吡啶季銨盐的混合物,通过离心,水洗,离心,过滤,冷冻干燥,如此重复3次,得到产品2.82克。HPLC测定表明,紫杉醇纯度为99.9%以上(图5)。(5) The mixture of paclitaxel and octadecylpyridinium trifluoroacetate quaternary ammonium salt obtained in step (4) was centrifuged, washed with water, centrifuged, filtered, and freeze-dried, and so repeated 3 times to obtain 2.82 grams of product. HPLC assay showed that the purity of paclitaxel was above 99.9% ( FIG. 5 ).
洗脱液和流动相中的溶剂经过精馏后可重复使用。水洗所得的三氟醋酸十八烷基吡啶季銨盐,浓缩,冷冻干燥后可重复使用。Solvents in the eluent and mobile phase can be reused after rectification. The obtained octadecylpyridinium trifluoroacetic acid quaternary ammonium salt was washed with water, concentrated, freeze-dried and reused.
该产品为白色结晶,旋光度[α]D 25=-54.6(c=0.2,MeOH),熔点为236~237℃,500MHz核磁共振图谱验证与紫杉醇标样相同,高分辨质谱(HR-ESI-MS)m/z 854.3397([M+H]+),相应的分子式为C47H51NO14。该产品与标准样品在HPLC分析中保留时间一致。The product is white crystal, optical rotation [α] D 25 = -54.6 (c = 0.2, MeOH), melting point is 236 ~ 237 ° C, 500MHz nuclear magnetic resonance spectrum verification is the same as paclitaxel standard sample, high resolution mass spectrometry (HR-ESI- MS) m/z 854.3397 ([M+H] + ), the corresponding molecular formula is C 47 H 51 NO 14 . The retention time of the product is consistent with that of the standard sample in HPLC analysis.
实施例2:Example 2:
(1)取人工栽培的3年树龄的曼地亚红豆杉的鲜枝叶100kg,用破碎机粉碎后置于2m3的提取罐中,然后加入90%甲醇550L,搅拌均匀,在40~50℃下间歇搅拌浸泡4小时。浸泡完成后,放出提取罐中的溶液,然后用同样方法浸泡3次。放出的甲醇溶液合并,置于浓缩罐中浓缩,至体积约为25L。提取罐中,向该溶液加入约250L石油醚,混合均匀后加250L水搅拌1小时,放置约30min形成两层,分出下层。向下层溶液加入约250L乙酸丙酯,混合均匀后,搅拌1小时,放置约30min形成两层。(1) Take 100kg of fresh branches and leaves of the 3-year-old Taxus Mandina cultivated artificially, put them in a 2m3 extraction tank after pulverizing with a crusher, then add 550L of 90% methanol, stir evenly, Soak with intermittent stirring for 4 hours. After soaking, release the solution in the extraction tank, and then soak 3 times in the same way. The released methanol solutions were combined and concentrated in a concentration tank to a volume of about 25L. In the extraction tank, add about 250L of petroleum ether to the solution, mix well, add 250L of water and stir for 1 hour, let it stand for about 30min to form two layers, and separate the lower layer. Add about 250L propyl acetate to the lower layer solution, mix evenly, stir for 1 hour, and let stand for about 30min to form two layers.
(2)放出下层乙酸丙酯萃取液,减压蒸发至干,形成棕色粉末1032克,经测定紫杉醇含量为3.31%。(2) The propyl acetate extract of the lower layer was released, evaporated to dryness under reduced pressure, and 1032 grams of brown powder was formed, and the paclitaxel content was determined to be 3.31%.
(3)将含3.31%的紫杉醇棕色粉末1kg,用丙酮溶解,同2kg的硅胶混合制备干样。干样置于装有10kg硅胶柱上,分别用30L的石油醚-乙酸乙酯(4∶1)、30L的石油醚-乙酸乙酯(1∶1)、50L的石油醚-乙酸乙酯(1∶5)和20L乙酸乙酯洗脱液,每10L收集一个馏分,用相同体积的容器接收得到相同体积的馏分1-20。馏分9-15蒸干后,为黄色或绿黄色固体粉末。馏分9-15中紫杉醇含量在15.0%~30.0%之间。(3) Dissolve 1 kg of paclitaxel brown powder containing 3.31% in acetone, and mix it with 2 kg of silica gel to prepare a dry sample. The dry sample was placed on a 10kg silica gel column, and was washed with 30L of petroleum ether-ethyl acetate (4:1), 30L of petroleum ether-ethyl acetate (1:1), and 50L of petroleum ether-ethyl acetate ( 1:5) and 20L of ethyl acetate eluent, one fraction was collected per 10L, and the same volume of fractions 1-20 was received with the same volume container. Fraction 9-15 is yellow or greenish yellow solid powder after evaporation to dryness. The content of paclitaxel in fractions 9-15 is between 15.0% and 30.0%.
(4)将紫杉醇含量在20.3%的样品,溶解于乙腈和含0.1%三氟醋酸水(30∶70)中,经C18反相高压液相色谱法分离,以含三氟醋酸十八烷基吡啶季銨盐(5mg/mL)的乙腈和含0.1%三氟醋酸水(30∶70)为流动相,流速为1ml/min,收集馏分1-35。馏分15-25,浓缩,得到紫杉醇晶体和三氟醋酸十八烷基吡啶季銨盐固体的混合物。(4) Dissolve the sample with paclitaxel content of 20.3% in acetonitrile and water (30:70) containing 0.1% trifluoroacetic acid, and separate by C 18 reverse phase high pressure liquid chromatography to obtain octadecane containing trifluoroacetic acid Acetonitrile based pyridinium quaternary ammonium salt (5 mg/mL) and water containing 0.1% trifluoroacetic acid (30:70) were used as the mobile phase at a flow rate of 1 ml/min, and fractions 1-35 were collected. Fractions 15-25 were concentrated to give a mixture of paclitaxel crystals and octadecylpyridinium trifluoroacetate as a solid.
(5)将此紫杉醇和三氟醋酸十八烷基吡啶季銨盐混合物。通过离心,水洗(300ml),再离心,过滤,如此重复3次,冷冻干燥。得到纯度为99.7%以上的紫杉醇,收率为91%。(5) The paclitaxel and octadecylpyridinium trifluoroacetate quaternary ammonium salt mixture. Centrifuged, washed with water (300ml), centrifuged again, filtered, and so repeated 3 times, freeze-dried. Paclitaxel with a purity of over 99.7% was obtained with a yield of 91%.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100227565A CN101560197B (en) | 2009-06-01 | 2009-06-01 | Method for extracting paclitaxel from artificially cultivated yew branches and leaves |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2009100227565A CN101560197B (en) | 2009-06-01 | 2009-06-01 | Method for extracting paclitaxel from artificially cultivated yew branches and leaves |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101560197A CN101560197A (en) | 2009-10-21 |
CN101560197B true CN101560197B (en) | 2011-07-06 |
Family
ID=41219198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2009100227565A Expired - Fee Related CN101560197B (en) | 2009-06-01 | 2009-06-01 | Method for extracting paclitaxel from artificially cultivated yew branches and leaves |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101560197B (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102949385A (en) * | 2012-11-05 | 2013-03-06 | 江苏红豆杉生物科技股份有限公司 | Yew branch and leaf extract, extraction method and applications thereof |
CN103804327A (en) * | 2012-11-15 | 2014-05-21 | 刘胜远 | Method for separating and purifying paclitaxel from paclitaxel-containing extract |
CN103193735B (en) * | 2013-03-26 | 2015-07-15 | 安徽和华生物医药科技有限公司 | Extraction method for taxus chinensis taxol activity extract |
CN104529951B (en) * | 2014-12-10 | 2019-05-10 | 宁波绿之健药业有限公司 | A kind of preparation method of natural Japanese yew alcohol |
CN105153076A (en) * | 2015-08-12 | 2015-12-16 | 江苏振宇环保科技有限公司 | Method for extracting paclitaxel from yew roots |
CN111393390A (en) * | 2019-01-02 | 2020-07-10 | 贵州罗贝罗生物科技有限公司 | Method for efficiently extracting paclitaxel from taxus chinensis |
CN110003143A (en) * | 2019-04-15 | 2019-07-12 | 云南汉德生物技术有限公司 | A method of extracting natural Japanese yew alcohol |
CN110845449A (en) * | 2019-10-12 | 2020-02-28 | 普洱大华林业科技有限公司 | Method for extracting paclitaxel from taxus chinensis |
CN112409301A (en) * | 2020-11-30 | 2021-02-26 | 唐芳艳 | Extraction process of paclitaxel extract and paclitaxel composition |
CN112881315A (en) * | 2021-01-25 | 2021-06-01 | 上海电力大学 | Method for measuring concentration of octadecylamine in water and application |
CN113896695B (en) * | 2021-05-26 | 2023-12-01 | 四川杉宝生物科技有限公司 | Method for simultaneously extracting cephalomannine and paclitaxel from Mandya yew |
CN113831307A (en) * | 2021-09-30 | 2021-12-24 | 王强 | Supercritical CO2Method for extracting paclitaxel and its concomitant product by fluid extraction method |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060014968A1 (en) * | 2004-07-15 | 2006-01-19 | Indena S.P.A. | Methods for obtaining paclitaxel from taxus plants |
US7105187B1 (en) * | 2003-02-28 | 2006-09-12 | University Of Portland | Method for obtaining taxanes |
CN1994995A (en) * | 2006-01-06 | 2007-07-11 | 上海百灵医药科技有限公司 | Method for extracting and purifying sequoyitol |
-
2009
- 2009-06-01 CN CN2009100227565A patent/CN101560197B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7105187B1 (en) * | 2003-02-28 | 2006-09-12 | University Of Portland | Method for obtaining taxanes |
US20060014968A1 (en) * | 2004-07-15 | 2006-01-19 | Indena S.P.A. | Methods for obtaining paclitaxel from taxus plants |
CN1994995A (en) * | 2006-01-06 | 2007-07-11 | 上海百灵医药科技有限公司 | Method for extracting and purifying sequoyitol |
Non-Patent Citations (1)
Title |
---|
张志强等.正相和反相柱层析组合分离纯化紫杉醇.《生物工程学报》.2000,第16卷(第1期),69-73. * |
Also Published As
Publication number | Publication date |
---|---|
CN101560197A (en) | 2009-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101560197B (en) | Method for extracting paclitaxel from artificially cultivated yew branches and leaves | |
AU760242B2 (en) | Method for high yield extraction of paclitaxel from paclitaxel-containing material | |
CN101445545B (en) | Method for separating triptolide from thunder god vine leaves | |
Watchueng et al. | Efficient purification of paclitaxel from yews using high-performance displacement chromatography technique | |
JP2015178520A (en) | Method for preparing highly pure anhydrous crystalline docetaxel | |
CN105481711B (en) | Hydroxy-beta-sanshool monomer preparation method | |
CN108707133A (en) | A kind of Lignanoids compounds and its method and the application that separation is extracted from Hawk tea | |
CN102653528A (en) | Method for separating purified paclitaxel and 10 diaminobenzidine (DAB) III by utilizing macroporous resin | |
CN101921277A (en) | A kind of method for simultaneously preparing duckbilline and duckbilline from camel succulents | |
US20070112207A1 (en) | Method for separation and purification of 13-dehydroxybaccatin iii and 10-deacetylpaclitaxel from taxans-containing materials | |
JP2965168B2 (en) | Method for mass production of taxol from Taxus plants | |
CN104327066B (en) | Method for rapidly and efficiently extracting carboline alkaloids | |
EP1818328A1 (en) | Chromatographic method for the isolation and purification of taxane derivatives | |
US7169307B2 (en) | Process for the extraction of paclitaxel and 9-dihydro-13-acetylbaccatin III from Taxus | |
CN104163754A (en) | Method for extraction and separating of high purity resveratrol from peanut root | |
CN101045718B (en) | A method for separating and purifying 10-deacetylbaccatin III | |
CN103113432A (en) | Iridoids, and preparation method and application thereof | |
CN100422188C (en) | Method for separating and preparing Tripterygium wilfordii alkaloid monomer from tripterygium wilfordii by countercurrent chromatography | |
CN112321664B (en) | Method for extracting, separating and purifying Inonotinol | |
CN1244566C (en) | Method of preparing taxadol from leaf and twing of planted taxus chinensis | |
CN1486306A (en) | Isolation of taxanes | |
CN114177207A (en) | Method for preparing taxine by using ethyl acetate extraction raffinate of taxus chinensis branches and leaves | |
CN102249898B (en) | Method for extracting antitumor component caffeic acid from Elsholtzia splendens | |
CN1328269C (en) | Process for preparing taxol | |
CN1442413A (en) | Method of extracting medical taxadol and its derivative using regenerable resources |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110706 Termination date: 20130601 |